{
    "organizations": [],
    "uuid": "f947fd61739ccea503ff23af3744492f51a3befc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-soleno-therapeutics-says-qtrly-los/brief-soleno-therapeutics-says-qtrly-loss-per-share-from-continuing-operations-0-17-sec-filing-idUSFWN1SN0IR",
    "ord_in_thread": 0,
    "title": "BRIEF-Soleno Therapeutics Says QTRLY Loss Per Share From Continuing Operations $0.17 - SEC Filing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 16 (Reuters) - Soleno Therapeutics Inc:\n* SOLENO THERAPEUTICS SAYS QTRLY LOSS PER SHARE FROM CONTINUING OPERATIONS $0.17 - SEC FILING\n* SOLENO THERAPEUTICS INC - Q1 LOSS PER SHARE $0.19 Source text: ( bit.ly/2Ip1Llc ) Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-16T18:21:00.000+03:00",
    "crawled": "2018-05-17T14:24:50.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "soleno",
        "therapeutic",
        "inc",
        "soleno",
        "therapeutic",
        "say",
        "qtrly",
        "loss",
        "per",
        "share",
        "continuing",
        "operation",
        "sec",
        "filing",
        "soleno",
        "therapeutic",
        "inc",
        "q1",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "company",
        "coverage"
    ]
}